Botswana - Import of Heparin for Therapeutic Use
Since 2014, Botswana Import of Heparin for Therapeutic Use jumped by 29.8% year on year. In 2019, the country was number 109 among other countries in Import of Heparin for Therapeutic Use at $31,033.84. Botswana is overtaken by Trinidad and Tobago, which was ranked number 108 at $32,114 and is followed by Ghana with $27,015.39. France lead the ranking with $960,128,653.6 in 2019, a decrease of 6.6% compared to 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize recorded the best 5 years average growth at +183.7% per year, while Mauritania recorded the worst performance at -81.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 31,033.84 |
| 2018 | 38,586.31 |
| 2017 | 17,624.11 |
| 2016 | 8,649.00 |
| 2015 | 20,929.00 |
Download all data from 2000 to 2019
How does Botswana rank in Import of Heparin for Therapeutic Use?
| # | 152 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
France
|
960,128,653.60 | 2019 | -6.6 % | -5.3 % | View data | |
| 2 |
#2
United States
|
422,842,642.50 | 2019 | +0.9 % | +2.3 % | View data | |
| 108 |
#108
Trinidad and Tobago
|
32,114.00 | 2019 | -42.4 % | -18.2 % | View data | |
| 109 |
#109
Botswana
|
31,033.84 | 2019 | -19.6 % | +29.8 % | View data | |
| 110 |
#110
Ghana
|
27,015.38 | 2018 | -73.8 % | +27.4 % | View data | |